SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-03-078611
Filing Date
2003-11-12
Accepted
2003-11-12 16:56:33
Documents
9
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2003 d10q.htm 10-Q 421986
3 AMENDMENT NO.1 TO COLLABORATION AGREEMENT DATED JULY 28, 2003 dex101.htm EX-10.1 85333
4 SEVERANCE AND RELEASE AGREEMENT WITH AMY P. SING DATED AUGUST 7, 2003 dex102.htm EX-10.2 43075
5 CHANGE OF CONTROL AGREEMENT WITH ERIC L. DOBMEIER DATED MARCH 29, 2002 dex103.htm EX-10.3 24033
6 CHANGE OF CONTROL AGREEMENT WITH DOUGLAS E. WILLIAMS DATED SEPTEMBER 30, 2003 dex104.htm EX-10.4 20176
7 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) dex311.htm EX-31.1 9607
8 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) dex312.htm EX-31.2 9590
9 CERTIFICATION OF CEO PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 3162
10 CERTIFICATION OF CFO PURSUANT TO 18 U.S.C. SECTION 1350 dex322.htm EX-32.2 3156
  Complete submission text file 0001193125-03-078611.txt   622954
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
SEATTLE GENETICS INC /WA (Filer) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-50266 | Film No.: 03994574
SIC: 2836 Biological Products, (No Diagnostic Substances)